WEKO3
AND
アイテム
{"_buckets": {"deposit": "cc5aa8ca-21a9-4a98-8da7-3dd80795e98e"}, "_deposit": {"id": "8529", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "8529"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00008529"}, "item_7_alternative_title_1": {"attribute_name": "\u305d\u306e\u4ed6\u306e\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_alternative_title": "A Case\u3000of\u3000Long\uff0dterm\u3000Disease\uff0dfree\u3000Survival\u3000Due\u3000to\u3000Multimodal\u3000Therapy\u3000for Synchronous\u3000Multiple\u3000Liver\u3000Metastases\u3000of\u3000Sigmoid\u3000Colon\u3000Cancer"}]}, "item_7_biblio_info_6": {"attribute_name": "\u66f8\u8a8c\u60c5\u5831", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2015-12", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "12", "bibliographicPageEnd": "767", "bibliographicPageStart": "761", "bibliographicVolumeNumber": "129", "bibliographic_titles": [{"bibliographic_title": "\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c"}, {"bibliographic_title": "\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "\u6284\u9332", "attribute_value_mlt": [{"subitem_description": "\u75c7\u4f8b\u306f71\u6b73\u7537\u6027. \u4e3b\u8a34\u306f\u7279\u306b\u306a\u3057. \u691c\u8a3a\u3067\u4fbf\u6f5c\u8840\u967d\u6027\u3092\u6307\u6458\u3055\u308c\u7cbe\u67fb\u3092\u65bd\u884c, \u809d\u4e21\u8449\u306b\u8a087\u500b\u306e\u591a\u767a\u809d\u8ee2\u79fb\u3092\u4f34\u3046\u9032\u884cS\u72b6\u7d50\u8178\u764c\u3068\u8a3a\u65ad\u3055\u308c\u305f. \u539f\u767a\u5de3\u5207\u9664(pT3N1M1 (H2) pStage IV)\u3092\u65bd\u884c\u3057\u305f\u5f8c, Capecitabine+Oxaliplatin+Bevacizumab\u306b\u3088\u308b\u5168\u8eab\u5316\u5b66\u7642\u6cd5\u3092\u8a086\u30b3\u30fc\u30b9\u65bd\u884c\u3057\u305f. \u6709\u5bb3\u4e8b\u8c61\u306f\u7279\u306b\u8a8d\u3081\u305a, Response Evaluation Criteria in Solid Tumors v1.1\u5224\u5b9a\u3067\u306f\u7e2e\u5c0f\u7387\u306f38.7%\u3067\u3042\u308aPartial Response\u3067\u3042\u3063\u305f. \u809d\u8ee2\u79fb\u306b\u5bfe\u3057\u3066\u5207\u9664\u53ef\u80fd\u3068\u5224\u65ad\u3057, \u809d\u5916\u5074\u533a\u57df\u5207\u9664+6\u304b\u6240\u306e\u809d\u90e8\u5206\u5207\u9664\u3092\u884c\u3044, \u6cbb\u7652\u5207\u9664\u3068\u306a\u3063\u305f. \u5207\u9664\u6a19\u672c\u306e\u75c5\u7406\u7d44\u7e54\u7d50\u679c\u3067\u306f5\u75c5\u5909\u306b\u817a\u764c\u304c\u8a8d\u3081\u3089\u308c, S\u72b6\u7d50\u8178\u764c\u809d\u8ee2\u79fb\u3068\u8a3a\u65ad\u3055\u308c\u305f. \u6b8b\u308a\u306e2\u75c5\u5909\u306b\u306f\u6b8b\u5b58\u816b\u760d\u3092\u8a8d\u3081\u306a\u304b\u3063\u305f. \u7d44\u7e54\u5b66\u7684\u52b9\u679c\u5224\u5b9a\u306fGrade 2\u3067\u3042\u3063\u305f. \u8853\u5f8c\u306bUFT/UZEL\u306b\u3088\u308b\u5316\u5b66\u7642\u6cd5\u30926\u304b\u6708\u9593\u884c\u3063\u305f. \u809d\u5207\u9664\u304b\u30891\u5e746\u304b\u6708\u5f8c, \u809dS5\u306b\u5b64\u7acb\u6027\u306e\u809d\u8ee2\u79fb\u3092\u8a8d\u3081\u305f\u305f\u3081, \u809dS5\u306e\u90e8\u5206\u5207\u9664\u8853\u3092\u65bd\u884c\u3057\u305f. \u305d\u306e\u5f8c\u306fUFT/UZEL\u3092\u7d99\u7d9a\u3057, \u5916\u6765\u901a\u9662\u4e2d\u3067\u3042\u308b. \u73fe\u5728, \u521d\u56de\u624b\u8853\u304b\u30895\u5e746\u304b\u6708, \u7121\u518d\u767a\u751f\u5b58\u4e2d\u3067\u3042\u308b. \u5207\u9664\u4e0d\u80fd\u30fb\u56f0\u96e3\u306a\u809d\u8ee2\u79fb\u3092\u6709\u3059\u308b\u5927\u8178\u764c\u306b\u5bfe\u3057\u3066, Capecitabine+Oxaliplatin+Bevacizumab\u3092\u7528\u3044\u305f\u5168\u8eab\u5316\u5b66\u7642\u6cd5\u306f\u6709\u7528\u3067\u3042\u308b.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "\u8457\u8005\u5225\u540d", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "59330", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Yagi, Ryoma"}]}, {"nameIdentifiers": [{"nameIdentifier": "59331", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Kameyama, Hitoshi"}]}, {"nameIdentifiers": [{"nameIdentifier": "59332", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Abe, Kaoru"}]}, {"nameIdentifiers": [{"nameIdentifier": "59333", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Yamada, Saki"}]}, {"nameIdentifiers": [{"nameIdentifier": "59334", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Hosoi, Mana"}]}, {"nameIdentifiers": [{"nameIdentifier": "59335", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Tajima, Yosuke"}]}, {"nameIdentifiers": [{"nameIdentifier": "59336", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Nakano, Mae"}]}, {"nameIdentifiers": [{"nameIdentifier": "59337", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Nakano, Masato"}]}, {"nameIdentifiers": [{"nameIdentifier": "59338", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Shimada, Yoshifumi"}]}, {"nameIdentifiers": [{"nameIdentifier": "59339", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Wakai, Toshifumi"}]}, {"nameIdentifiers": [{"nameIdentifier": "59340", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Hasegawa, Go"}]}]}, "item_7_publisher_7": {"attribute_name": "\u51fa\u7248\u8005", "attribute_value_mlt": [{"subitem_publisher": "\u65b0\u6f5f\u533b\u5b66\u4f1a"}]}, "item_7_select_19": {"attribute_name": "\u8457\u8005\u7248\u30d5\u30e9\u30b0", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "\u66f8\u8a8c\u30ec\u30b3\u30fc\u30c9ID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "\u8457\u8005", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "\u516b\u6728, \u4eae\u78e8"}], "nameIdentifiers": [{"nameIdentifier": "59319", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "\u4e80\u5c71, \u4ec1\u53f2"}], "nameIdentifiers": [{"nameIdentifier": "59320", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "\u963f\u90e8, \u99a8"}], "nameIdentifiers": [{"nameIdentifier": "59321", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "\u5c71\u7530, \u6c99\u5b63"}], "nameIdentifiers": [{"nameIdentifier": "59322", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "\u7d30\u4e95, \u611b"}], "nameIdentifiers": [{"nameIdentifier": "59323", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "\u7530\u5cf6, \u967d\u4ecb"}], "nameIdentifiers": [{"nameIdentifier": "59324", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "\u4e2d\u91ce, \u9ebb\u6075"}], "nameIdentifiers": [{"nameIdentifier": "59325", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "\u4e2d\u91ce, \u96c5\u4eba"}], "nameIdentifiers": [{"nameIdentifier": "59326", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "\u5cf6\u7530, \u80fd\u53f2"}], "nameIdentifiers": [{"nameIdentifier": "59327", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "\u82e5\u4e95, \u4fca\u6587"}], "nameIdentifiers": [{"nameIdentifier": "59328", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "\u9577\u8c37\u5ddd, \u525b"}], "nameIdentifiers": [{"nameIdentifier": "59329", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "\u30d5\u30a1\u30a4\u30eb\u60c5\u5831", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-06"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "129(12)_761-767.pdf", "filesize": [{"value": "1.1 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1100000.0, "url": {"label": "129(12)_761-767.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/8529/files/129(12)_761-767.pdf"}, "version_id": "3ca0888b-997e-4b01-b462-1d0e52e848a7"}]}, "item_keyword": {"attribute_name": "\u30ad\u30fc\u30ef\u30fc\u30c9", "attribute_value_mlt": [{"subitem_subject": "\u5927\u8178\u764c", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u540c\u6642\u6027\u809d\u8ee2\u79fb", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Capecitabine", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Oxaliplatin", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Bevacizumab", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "\u8a00\u8a9e", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "\u96c6\u5b66\u7684\u6cbb\u7642\u306b\u3088\u308a\u9577\u671f\u7121\u518d\u767a\u751f\u5b58\u304c\u5f97\u3089\u308c\u305fS\u72b6\u7d50\u8178\u764c\u540c\u6642\u6027\u591a\u767a\u809d\u8ee2\u79fb\u306e1\u4f8b", "item_titles": {"attribute_name": "\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_title": "\u96c6\u5b66\u7684\u6cbb\u7642\u306b\u3088\u308a\u9577\u671f\u7121\u518d\u767a\u751f\u5b58\u304c\u5f97\u3089\u308c\u305fS\u72b6\u7d50\u8178\u764c\u540c\u6642\u6027\u591a\u767a\u809d\u8ee2\u79fb\u306e1\u4f8b"}, {"subitem_title": "\u96c6\u5b66\u7684\u6cbb\u7642\u306b\u3088\u308a\u9577\u671f\u7121\u518d\u767a\u751f\u5b58\u304c\u5f97\u3089\u308c\u305fS\u72b6\u7d50\u8178\u764c\u540c\u6642\u6027\u591a\u767a\u809d\u8ee2\u79fb\u306e1\u4f8b", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["453/456", "471/537/538/904"], "permalink_uri": "http://hdl.handle.net/10191/44313", "pubdate": {"attribute_name": "\u516c\u958b\u65e5", "attribute_value": "2016-10-14"}, "publish_date": "2016-10-14", "publish_status": "0", "recid": "8529", "relation": {}, "relation_version_is_last": true, "title": ["\u96c6\u5b66\u7684\u6cbb\u7642\u306b\u3088\u308a\u9577\u671f\u7121\u518d\u767a\u751f\u5b58\u304c\u5f97\u3089\u308c\u305fS\u72b6\u7d50\u8178\u764c\u540c\u6642\u6027\u591a\u767a\u809d\u8ee2\u79fb\u306e1\u4f8b"], "weko_shared_id": null}
集学的治療により長期無再発生存が得られたS状結腸癌同時性多発肝転移の1例
http://hdl.handle.net/10191/44313
14bed66a-a615-4f2c-bf40-6ec5a94224ad
名前 / ファイル | ライセンス | アクション | |
---|---|---|---|
![]() |
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2016-10-14 | |||||
タイトル | ||||||
タイトル | 集学的治療により長期無再発生存が得られたS状結腸癌同時性多発肝転移の1例 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | 集学的治療により長期無再発生存が得られたS状結腸癌同時性多発肝転移の1例 | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 大腸癌 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 同時性肝転移 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Capecitabine | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Oxaliplatin | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Bevacizumab | |||||
資源タイプ | ||||||
資源 | http://purl.org/coar/resource_type/c_6501 | |||||
タイプ | departmental bulletin paper | |||||
その他のタイトル | ||||||
その他のタイトル | A Case of Long-term Disease-free Survival Due to Multimodal Therapy for Synchronous Multiple Liver Metastases of Sigmoid Colon Cancer | |||||
著者 |
八木, 亮磨
× 八木, 亮磨× 亀山, 仁史× 阿部, 馨× 山田, 沙季× 細井, 愛× 田島, 陽介× 中野, 麻恵× 中野, 雅人× 島田, 能史× 若井, 俊文× 長谷川, 剛 |
|||||
著者別名 | ||||||
識別子 | ||||||
識別子 | 59330 | |||||
識別子Scheme | WEKO | |||||
姓名 | ||||||
姓名 | Yagi, Ryoma | |||||
著者別名 | ||||||
識別子 | ||||||
識別子 | 59331 | |||||
識別子Scheme | WEKO | |||||
姓名 | ||||||
姓名 | Kameyama, Hitoshi | |||||
著者別名 | ||||||
識別子 | ||||||
識別子 | 59332 | |||||
識別子Scheme | WEKO | |||||
姓名 | ||||||
姓名 | Abe, Kaoru | |||||
著者別名 | ||||||
識別子 | ||||||
識別子 | 59333 | |||||
識別子Scheme | WEKO | |||||
姓名 | ||||||
姓名 | Yamada, Saki | |||||
著者別名 | ||||||
識別子 | ||||||
識別子 | 59334 | |||||
識別子Scheme | WEKO | |||||
姓名 | ||||||
姓名 | Hosoi, Mana | |||||
著者別名 | ||||||
識別子 | ||||||
識別子 | 59335 | |||||
識別子Scheme | WEKO | |||||
姓名 | ||||||
姓名 | Tajima, Yosuke | |||||
著者別名 | ||||||
識別子 | ||||||
識別子 | 59336 | |||||
識別子Scheme | WEKO | |||||
姓名 | ||||||
姓名 | Nakano, Mae | |||||
著者別名 | ||||||
識別子 | ||||||
識別子 | 59337 | |||||
識別子Scheme | WEKO | |||||
姓名 | ||||||
姓名 | Nakano, Masato | |||||
著者別名 | ||||||
識別子 | ||||||
識別子 | 59338 | |||||
識別子Scheme | WEKO | |||||
姓名 | ||||||
姓名 | Shimada, Yoshifumi | |||||
著者別名 | ||||||
識別子 | ||||||
識別子 | 59339 | |||||
識別子Scheme | WEKO | |||||
姓名 | ||||||
姓名 | Wakai, Toshifumi | |||||
著者別名 | ||||||
識別子 | ||||||
識別子 | 59340 | |||||
識別子Scheme | WEKO | |||||
姓名 | ||||||
姓名 | Hasegawa, Go | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | 症例は71歳男性. 主訴は特になし. 検診で便潜血陽性を指摘され精査を施行, 肝両葉に計7個の多発肝転移を伴う進行S状結腸癌と診断された. 原発巣切除(pT3N1M1 (H2) pStage IV)を施行した後, Capecitabine+Oxaliplatin+Bevacizumabによる全身化学療法を計6コース施行した. 有害事象は特に認めず, Response Evaluation Criteria in Solid Tumors v1.1判定では縮小率は38.7%でありPartial Responseであった. 肝転移に対して切除可能と判断し, 肝外側区域切除+6か所の肝部分切除を行い, 治癒切除となった. 切除標本の病理組織結果では5病変に腺癌が認められ, S状結腸癌肝転移と診断された. 残りの2病変には残存腫瘍を認めなかった. 組織学的効果判定はGrade 2であった. 術後にUFT/UZELによる化学療法を6か月間行った. 肝切除から1年6か月後, 肝S5に孤立性の肝転移を認めたため, 肝S5の部分切除術を施行した. その後はUFT/UZELを継続し, 外来通院中である. 現在, 初回手術から5年6か月, 無再発生存中である. 切除不能・困難な肝転移を有する大腸癌に対して, Capecitabine+Oxaliplatin+Bevacizumabを用いた全身化学療法は有用である. | |||||
書誌情報 |
新潟医学会雑誌 en : 新潟医学会雑誌 巻 129, 号 12, p. 761-767, 発行日 2015-12 |
|||||
出版者 | ||||||
出版者 | 新潟医学会 | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00290440 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00182415 | |||||
著者版フラグ | ||||||
値 | publisher |